Tower Research Capital LLC (Trc) Icosavax, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$5.95 - $15.79 $27,048 - $71,781	4,546 Added 208.34%	6,728 $106,000
Q3 2023 Nov 14, 2023	BUY	$7.22 - $10.05 $880 - $1,226	122 Added 5.92%	2,182 $16,000
Q2 2023 Aug 14, 2023	SELL	$4.89 - $10.57 $98,919 - $213,820	-20,229 Reduced 90.76%	2,060 $20,000
Q1 2023 May 09, 2023	BUY	$5.62 - $11.51 $117,514 - $240,674	20,910 Added 1516.32%	22,289 $129,000
Q4 2022 Feb 10, 2023	SELL	$2.32 - $10.97 $29,134 - $137,761	-12,558 Reduced 90.11%	1,379 $11,000

Q3 2022 Nov 10, 2022	BUY	$3.09 - $9.21 $37,790 - $112,638	12,230 Added 716.46%	13,937 $44,000
Q2 2022 Aug 15, 2022	SELL	$5.7 - $10.33 $2,439 - $4,421	-428 Reduced 20.05%	1,707 $10,000
Q1 2022 May 12, 2022	BUY	$4.41 - $22.5 $2,535 - $12,937	575 Added 36.86%	2,135 $15,000
Q4 2021 Feb 14, 2022	BUY	$21.07 - $34.98 $25,831 - $42,885	1,226 Added 367.07%	1,560 $36,000
Q3 2021 Nov 15, 2021	BUY	$24.85 - $40.25 $8,299 - $13,443	334 New	334 $10,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.